- Record: found
- Abstract: found
- Article: not found
Adjuvant mitotane treatment for adrenocortical carcinoma.
Massimo Terzolo
1 ,
Alberto Angeli ,
Martin Fassnacht ,
Fulvia Daffara ,
Libuse Tauchmanova ,
Pier Antonio Conton ,
Ruth Rossetto ,
Lisa Buci ,
Paola Sperone ,
Erika Grossrubatscher ,
Giuseppe Reimondo ,
Enrico Bollito ,
Mauro Papotti ,
Wolfgang Saeger ,
Stefanie Hahner ,
Ann-Cathrin Koschker ,
Emanuela Arvat ,
Bruno Ambrosi ,
Paola Loli ,
Gaetano Lombardi ,
Massimo Mannelli ,
Paolo Bruzzi ,
Franco Mantero ,
Bruno Allolio ,
Luigi Dogliotti ,
Alfredo Berruti
Jun 07 2007
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Adrenocortical carcinoma is a rare neoplasm characterized by a high risk of recurrence after radical resection. Whether the use of mitotane is beneficial as an adjuvant treatment has been controversial. Our aim was to evaluate the efficacy of adjuvant mitotane in prolonging recurrence-free survival.